Comparing two preventives for episodic migraine headaches
Treatments studied
Part of Brain & nervous system clinical trials.
This trial compares two medicines taken daily to prevent migraine headaches, with the goal of reducing how often they happen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 60 years old.
- You have episodic migraines – meaning 4 or more migraine days per month but not chronic migraines.
- You have not used any other migraine preventive medicine in the past month.
- You do not have other types of headaches (like headaches from injury or illness).
- You are not pregnant or breastfeeding.
- You do not have serious kidney, liver, or heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
This trial compares two different first-time preventive treatments for migraine in a primary care setting. If you qualify, you'll receive one of the study medications, and the research team will track how well it reduces your migraine days.
This study compares two common medicines, nortriptyline and amitriptyline, to see which works better at preventing migraines. Both are antidepressants that are often used to stop migraines before they start.
This trial tests if adding magnesium to a standard migraine medication (prochlorperazine) helps treat migraines more effectively. It could be a good option for adults with migraines who haven't taken these drugs recently.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial tests whether an oral capsule called butylphthalide (also known as NBP) can help prevent migraine attacks in adults who get them regularly. If you have migraines 4–14 days per month, this study may offer a new preventive option.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.